Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ROCKET PHARMACEUTICALS, INC.

(RCKT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is focused on developing gene therapy treatment options for rare, devastating diseases. The CompanyÔÇÖs multi-platform development approach applies the well-established lentiviral vector (LVV) and adeno-associated viral vector (AAV) gene therapy platforms. The CompanyÔÇÖs lead clinical program is a LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a genetic disease that leads to bone marrow failure and potentially cancer. Its additional pipeline programs for bone marrow-derived disorders are for Pyruvate Kinase Deficiency (PKD), Leukocyte Adhesion Deficiency-I (LAD-I) and Infantile Malignant Osteopetrosis (IMO). The Company is also developing an AAV-based gene therapy program for pediatric heart failure indication, Danon disease.

Number of employees : 91 people.
Managers
NameAgeSinceTitle
Gaurav Shah, Dr.452018President, Chief Executive Officer & Director
Carlos Garcia-Parada552021Chief Financial Officer
Jonathan David Schwartz, Dr.562018Chief Medical Officer & SVP-Clinical Development
Kinnari Patel, Dr.41-Chief Operating Officer & EVP-Development
Pedro P. Granadillo722018Independent Director
Naveen Yalamanchi, Dr.432019Independent Director
Gotham Makker, Dr.462018Independent Director
David P. Southwell592018Independent Director
Carsten Boess532016Independent Director
Margareta Elisabeth Bj÷rk, Dr.592020Independent Director
Members of the board
NameAgeSinceTitle
Roderick T. Wong, Dr.422015Chairman
Gaurav Shah, Dr.452018President, Chief Executive Officer & Director
Pedro P. Granadillo722018Independent Director
Naveen Yalamanchi, Dr.432019Independent Director
Gotham Makker, Dr.462018Independent Director
David P. Southwell592018Independent Director
Carsten Boess532016Independent Director
Margareta Elisabeth Bj÷rk, Dr.592020Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 63,396,954 57,626,975 90.9% 0 0.0% 90.9%
Shareholders
NameEquities%
RTW Investments LP 15,460,119 24.4%
Wellington Management Co. LLP 3,659,077 5.77%
T. Rowe Price Associates, Inc. (Investment Management) 3,598,835 5.68%
Perceptive Advisors LLC 2,867,771 4.52%
The Vanguard Group, Inc. 2,794,313 4.41%
Tang Capital Management LLC 2,531,800 3.99%
Adage Capital Management LP 2,157,739 3.40%
RA Capital Management LP 2,107,149 3.32%
Westfield Capital Management Co. LP 1,663,652 2.62%
Lord, Abbett & Co. LLC 1,652,194 2.61%
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
ROCKET PHARMACEUTICALS, INC.-21.61%2 725
GILEAD SCIENCES, INC.14.40%83 591
WUXI APPTEC CO., LTD.35.04%69 433
BIONTECH SE181.53%55 429
REGENERON PHARMACEUTICALS9.66%54 864
VERTEX PHARMACEUTICALS-20.66%48 542
BEIGENE, LTD.32.45%31 674
GENMAB A/S6.17%27 448
ARGENX SE7.60%15 958
HUALAN BIOLOGICAL ENGINEERING INC.-14.20%10 333
NEUROCRINE BIOSCIENCES, INC.4.60%9 479
ARROWHEAD PHARMACEUTICALS, INC.14.81%9 169
DENALI THERAPEUTICS INC.-15.20%8 608
MIRATI THERAPEUTICS, INC.-25.77%8 386
REMEGEN CO., LTD.33.79%7 949
FATE THERAPEUTICS, INC.-8.14%7 855
ASCENDIS PHARMA A/S-16.79%7 470
ACCELERON PHARMA INC.-4.49%7 417
EXELIXIS, INC.10.71%6 963
GW PHARMACEUTICALS PLC89.72%6 907
AKESO, INC.70.26%6 619